Estimated NTA as at 29 May 2026
Release authorised by Matthew Rowe, Company Secretary
Australian Foundation Investment Company Limited (AFIC) – ABN 56 004 147 120
Level 21, 101 Collins Street, Melbourne Victoria 3000
(03) 9650 9911 | invest@afi.com.au | afi.com.au
Share Registrar
MUFG Corporate Markets (AU) Limited
au.investorcentre.mpms.mufg.com
Telephone: 1300 857 499
Telephone: +64 9 375 5998 (NZ)
Email: afi@cm.mpms.mufg.com
1 June 2026
The Manager
ASX Market Announcements
Australian Securities Exchange
Exchange Centre
Level 4
20 Bridge Street
Sydney NSW 2000
Electronic Lodgement
Australian Foundation Investment Company Limited
Estimated net tangible asset (NTA) backing per share
as at 29 May 2026
Pre-Tax NTA per share (estimated)
$7.74
AFI Share Price (ASX closing price on 29 May 2026)
$6.55
The Pre-Tax NTA is unaudited and indicative only. It is based on investments at market value and is before the provision for deferred tax
on unrealised gains or losses.
For more information visit our website: afi.com.au
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: AFT delivers double digit revenue growth and record earning2026-05-20
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 Results for announcement to the market AFT Pharmaceuticals Limited Reporting Period 12 months to 31 March 2026 Previo…”
- AFT — AFT Pharmaceuticals Limited: Annual Meeting and Closing Date for Director Nominations2026-05-24
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN 609 017 969 25 May 2026 Annual Meeting and Closing Date for Director Nominations AFT Pharmaceuticals Limited (NZX: AFT, ASX: AF…”